Velarion Records
Free. Unsubscribe any time.

Kymera Therapeutics, Inc. (KYMR)

Kymera Therapeutics, Inc. filed 46 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 9 reporting owners, covering 241 transactions and 2,887,731 shares. 36 carry the SEC's AFF10B5ONE flag; 10 name a plan only in a footnote. 9 results prints are on file in the same window.

What stands out

Trades in Kymera Therapeutics, Inc. 241

Adoption dates in Kymera Therapeutics, Inc. 2

Results prints in Kymera Therapeutics, Inc. 9

Trades before a print in Kymera Therapeutics, Inc. 8

Interval to Kymera Therapeutics, Inc.’s next reported results date

How the interval and sources are counted →

Adoption dates Kymera Therapeutics, Inc. states

Filing text: “10b5-1 trading plan adopted by the Reporting Person on December 11, 2025”

Reported results dates on file

A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.

Other companies with plan records

Sources: SEC EDGAR full-text search and the SEC submissions API.